The status and prospects for biotechnological approaches for attaining sustainable disease resistance

TY - CHAP

T1 - The status and prospects for biotechnological approaches for attaining sustainable disease resistance

AU - Collinge, David B.

AU - Mullins, Ewen

AU - Jensen, Birgit

AU - Jørgensen, Hans Jørgen Lyngs

PY - 2016/4/8

Y1 - 2016/4/8

N2 - The employment of biotechnology-based approaches can contribute towards developing more effective and higher levels of disease control. This chapter overviews the mechanisms of disease resistance, which show the greatest potential for being targeted by GM approaches. It discusses how one increased understanding of the processes of plant defence can lead to improved disease control. Disease resistance depends on a plethora of independent but interacting physiological mechanisms. The chapter introduces important pathogen and host factors involved in the interaction between pathogens and their hosts. Many types of organisms can cause diseases in plants, such as Fungi, Chromista and Protozoa. Ultimately, deciding on whether to engineer disease resistance focusing on MAMP-triggered immunity (MTI) or effector-triggered immunity (ETI) depends on the potential of the target pathogen to evolve in response to the resistance strategy adopted, which will affect the durability of the phenotypic resistance.

AB - The employment of biotechnology-based approaches can contribute towards developing more effective and higher levels of disease control. This chapter overviews the mechanisms of disease resistance, which show the greatest potential for being targeted by GM approaches. It discusses how one increased understanding of the processes of plant defence can lead to improved disease control. Disease resistance depends on a plethora of independent but interacting physiological mechanisms. The chapter introduces important pathogen and host factors involved in the interaction between pathogens and their hosts. Many types of organisms can cause diseases in plants, such as Fungi, Chromista and Protozoa. Ultimately, deciding on whether to engineer disease resistance focusing on MAMP-triggered immunity (MTI) or effector-triggered immunity (ETI) depends on the potential of the target pathogen to evolve in response to the resistance strategy adopted, which will affect the durability of the phenotypic resistance.

U2 - 10.1002/9781118867716.ch1

DO - 10.1002/9781118867716.ch1

M3 - Book chapter

SN - 9781118867761

SP - 1

EP - 20

BT - Plant pathogen resistance biotechnology

A2 - Collinge, David B.

PB - Wiley-Blackwell

ER -